Stonvex
Stonvex
StonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for FORR yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-14 | $6.26 | $6.44 | +2.88% | 0.0M |
| 05-15 | $6.36 | $6.60 | +3.77% | 0.1M |
| 05-18 | $6.51 | $6.65 | +2.07% | 0.1M |
| 05-19 | $6.57 | $6.75 | +2.74% | 0.2M |
| 05-20 | $6.73 | $6.76 | +0.45% | 0.1M |
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $85.45M | $396.89M | $295.83M | $201.53M |
Operating Income | $-18.63M | $-113.17M | $-76.18M | $-80.64M |
Net Income | $-21.82M | $-119.36M | $-85.48M | $-83.36M |
EPS (Diluted) | $-1.14 | $-6.28 | $-4.49 | $-4.39 |
Total Assets | $409.07M | $404.03M | $414.18M | $436.04M |
Total Liabilities | $303.01M | $277.51M | $256.51M | $276.50M |
Cash & Equivalents | $73.90M | $63.34M | $65.12M | $67.77M |
Free Cash Flow OCF − CapEx | $19.38M | $18.09M | $22.37M | $21.85M |
Shares Outstanding | 19.18M | 19.01M | 18.99M | 19.08M |
FORR is in the extended universe. We surface dollar-volume + price-change percentiles for every US-listed name, but the full 6-factor DNA breakdown (momentum, news, sentiment, flow, relative strength) is only computed on the curated 1137-name primary list.
DNA analysis is not available for this ticker.